The Lancet3h
The gut–bone axis: implications of gut hormone-based therapies for bone health
Historical trends and future projections of the number of people with overweight and obesity suggest alarming parallel ...
Computer Weekly1d
Danish supercomputer to drive innovation
Supercomputer project will add a competitive edge to drive innovation and growth among Denmark’s enterprises and research ...
The Davis Enterprise3d
Partnership develops future food, health leaders
UC Davis’ Innovation Institute for Food and Health, UC Investments and Denmark’s Novo Nordisk Foundation announced a unique ...
News-Medical.Net3d
Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025
Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus® (oral ...